KIR3DL1 and skin basal cell carcinoma: We observed a significantly higher frequency of KIR3DL1 in the BCC compared to the healthy controls (98% vs. 91.1%, p = 0.0381, OR = 4.78, 95% CI = 1.108 to 20.62) but was not significant, based on adjusted p value <0.025 after Bonferroni correction.